Nanjing, China

Bei Wang

This inventor holds 1 USPTO granted patent. Top assignee: Jiangsu Medolution Ltd. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bei Wang. Retrieved from https://idiyas.com/inventor/bei-wang-ke3be381

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bei Wang’s Pharmaceutical Formulation Patent.

Introduction

Bei Wang is a woman inventor associated with Nanjing, China. Her patent work includes a pharmaceutical composition based on a substituted crotonamide compound and a method for preparing it.

Latest Patents

The supplied information identifies one patent for Bei Wang: “Substituted crotonamide pharmaceutical composition and preparation method therefor.” It describes a composition containing 5–50 parts of the active compound, (E)-N-(3-cyano-7-ethoxy-4-(3-ethynylphenylamino)quinolin-6-yl)-4-(dimethylamino)but-2-enamide maleate; 40–120 parts of a carbohydrate filler; 2–20 parts of a disintegrant; 0–6 parts of an adhesive; and 0.5–5 parts of a lubricant. The patent also covers a method for preparing the composition. The supplied record lists 1 patent.

Career Highlights

Wang is associated with Jiangsu Medolution Ltd. Her listed patent focuses on pharmaceutical formulation and preparation, specifying ingredient categories and quantity ranges for the composition.

Collaborations

The supplied information names Haitao Tang and Bin Ge as Wang’s coworkers. Their shared association with Jiangsu Medolution Ltd. provides context for her professional collaborations.

Conclusion

Bei Wang’s listed invention concerns the formulation and preparation of a substituted crotonamide pharmaceutical composition, reflecting her patent-related work with Jiangsu Medolution Ltd.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…